ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 339 filers reported holding ACCELERON PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $15,799,000 | +39.7% | 91,800 | +1.9% | 0.94% | +5.7% |
| Q2 2021 | $11,307,000 | -7.5% | 90,100 | 0.0% | 0.89% | -16.0% |
| Q1 2021 | $12,219,000 | -1.7% | 90,100 | -7.3% | 1.06% | +8.8% |
| Q4 2020 | $12,436,000 | +33.1% | 97,200 | +17.1% | 0.97% | +27.3% |
| Q3 2020 | $9,340,000 | +50.8% | 83,000 | +27.7% | 0.76% | -4.4% |
| Q2 2020 | $6,192,000 | +658.8% | 65,000 | +170.8% | 0.80% | +128.6% |
| Q2 2016 | $816,000 | – | 24,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |